| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/16/2008 | CN101220374A Fowl pox virus double-gene expression carrier (PG7.5N) |
| 07/16/2008 | CN101220373A Recombined viral vectors and uses thereof |
| 07/16/2008 | CN101220372A Recombined bifidobacteria -hRV/VP7 expression vector and oral administration vaccine thereof |
| 07/16/2008 | CN101220360A SiRNA sequence restraining caspase-3 gene expression |
| 07/16/2008 | CN101220359A SiRNA sequence restraining bak gene expression |
| 07/16/2008 | CN101220351A Method for constructing PRRSV gene deletion vaccine toxin strain by using Nsp2 gene deletion and uses thereof |
| 07/16/2008 | CN101219222A Application of PDCD4 recombined expression vector in preparing medicament for treating gonad cancer |
| 07/16/2008 | CN101219221A Adenovirus carrier vaccine carrying HIV gene |
| 07/16/2008 | CN101219218A Temperature sensing parents block polymer/iron oxide magnetic nano-carrier, preparation method and application thereof |
| 07/16/2008 | CN101219215A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/16/2008 | CN101219213A Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 07/16/2008 | CN101219205A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/16/2008 | CN100402654C Method of treating ischemic disease |
| 07/16/2008 | CN100402648C Human Nanog gene and its encoded protein and application |
| 07/16/2008 | CN100402643C 感染性克隆 Infectious clone |
| 07/16/2008 | CN100402090C Mucosa-immune composite adjuvant |
| 07/16/2008 | CN100402017C Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/15/2008 | US7399853 Modulation of glucagon receptor expression |
| 07/15/2008 | US7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 07/15/2008 | US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers |
| 07/15/2008 | US7399753 Transgenic cell comprising recombinant conditionally replicative adenovirus coding photoreactive protein which when combined with photosensitizer induces cytolysis/apoptosis in cells; tissue directed therapy |
| 07/15/2008 | US7399751 Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
| 07/15/2008 | US7399750 Methods for cardiac gene transfer |
| 07/15/2008 | US7399745 polypeptides, fragments and/or variants, used for treatment of metabolic disorders, such as diabetes and obesity; hypoglycemic agents |
| 07/15/2008 | US7399595 Means for the diagnosis and therapy of CTCL |
| 07/15/2008 | US7399473 Virus coat protein/receptor chimeras and method of use |
| 07/15/2008 | US7399466 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene |
| 07/15/2008 | US7399465 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 07/15/2008 | CA2290720C Nucleic acid binding polypeptide library |
| 07/15/2008 | CA2244176C Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2118235C Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 07/15/2008 | CA2113023C Tnf receptor promoter |
| 07/10/2008 | WO2008082721A2 Polymer-stabilized liposomal compositions and methods of use |
| 07/10/2008 | WO2008082659A1 Methods and compositions for treating keratin hyperproliferation disorders |
| 07/10/2008 | WO2008082282A1 A chitosan based polymer conjugate and a method for producing the same |
| 07/10/2008 | WO2008081701A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | WO2008081581A1 Foxp3 peptide vaccine |
| 07/10/2008 | WO2008063562A9 Materials and methods of introducing genetic material into living cells |
| 07/10/2008 | WO2008037458A3 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening |
| 07/10/2008 | WO2007008982A3 Methods and composition for modulating foxo1 activity and insulin signaling |
| 07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 07/10/2008 | US20080168573 Transgenic worms for use as bioreactor for expression of carboxylesterase-1for use in treatment of alzheimer's disease |
| 07/10/2008 | US20080167457 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/10/2008 | US20080167448 Immunoglobulin specific to prostate tumor associated protein (24P4C12) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080167260 Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats |
| 07/10/2008 | US20080167258 Genetically engineered RNA self replicating enzyme for use in removal of repetitve triplet codon associated with muscular dystrophy; gene therapeutics and RNA targeting |
| 07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
| 07/10/2008 | US20080167256 Double-stranded RNA (siRNA) capable of suppressing expression of Skp-2 gene; small cell lung cancer |
| 07/10/2008 | US20080167241 Mu-1, member of the cytokine receptor family |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080167219 converting factor IX into a molecule with enhanced activity which provides an alternative for replacement therapy and gene therapy for hemophilia B. Using recombinant techniques, factor IX with replacement at positions 86, 277, and 338 exhibits better clotting activity than recombinant wild type factor |
| 07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
| 07/10/2008 | US20080166797 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166710 Using polymorphism in mannose-binding lectin gene as evaluative tool in prediciting interferon efficacy in treatment of hepatitis infection |
| 07/10/2008 | US20080166709 MARKs as Modifiers of the p53 Pathway and Methods of Use |
| 07/10/2008 | US20080166379 Prepared from autologous lymphoma cells transfected with emm55; for canines; the modified cancer cells are highly immunogenic to the host, yet show no toxic side effects |
| 07/10/2008 | US20080166374 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 07/10/2008 | US20080166373 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS |
| 07/10/2008 | US20080166367 Custom Vectors for Treating and Preventing Pancreatic Cancer |
| 07/10/2008 | US20080166356 Treating bone disorders resulting in increased trabecular bone formation, decreased osteoblast and osteocyte apoptosis and increased osteoprogenitor differentiation |
| 07/10/2008 | US20080166354 Using monoclonal antibody specific to inhibitor of protease or of a non-proteolytic matrix-degrading enzyme (IPNME) as therapeutic tool in treatment of cell proliferative disorders |
| 07/10/2008 | DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody |
| 07/10/2008 | CA2674365A1 Foxp3 peptide vaccine |
| 07/10/2008 | CA2670658A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | CA2660448A1 Chd5 is a novel tumor suppressor gene |
| 07/09/2008 | EP1941537A2 Drug and gene delivery by polymer nanonozzle and nanotip cell patch |
| 07/09/2008 | EP1941060A2 Protein demethylases comprising a jmjc domain |
| 07/09/2008 | EP1941028A2 Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes. |
| 07/09/2008 | EP1940862A2 Allele-specific rna interference |
| 07/09/2008 | EP1940472A1 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
| 07/09/2008 | EP1940471A1 IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF |
| 07/09/2008 | EP1940458A1 Compositions for and methods of granzyme b inhibition |
| 07/09/2008 | EP1940355A2 Drug delivery nanocarriers targeted by landscape phage |
| 07/09/2008 | EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets |
| 07/09/2008 | EP1408109B1 Novel method for the induction of cellular senescence and method for screening anti-aging agent |
| 07/09/2008 | EP1366160B1 Mini-dystrophin nucleic acid and peptide sequences |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP0932674B1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES |
| 07/09/2008 | CN101217973A Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide |
| 07/09/2008 | CN101217875A Prevention of chronic rejection in solid organ transplantation |
| 07/09/2008 | CN101215563A KDR siRNA and application thereof |
| 07/09/2008 | CN101214381A Acute promyelocytic leukemia DNA vaccine PML-RAR alpha-hGM-CSF and preparation and application thereof |
| 07/09/2008 | CN101214380A Method and carrier complexes for delivering molecules to cells |
| 07/09/2008 | CN100400667C Method for wrapping toxoplasmosis pGRA4 eukaryotic expression plasmid using liposome and uses |
| 07/09/2008 | CN100400101C Vaccines containing ribavirin and methods of use thereof |
| 07/08/2008 | US7396919 Charge reversal of polyion complexes |
| 07/08/2008 | US7396909 Toxoplasma gondii proteins |
| 07/08/2008 | US7396904 Tumor-associated peptides binding to MHC-molecules |
| 07/08/2008 | US7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 07/08/2008 | US7396822 Comprising plasmid having open reading frame encoding antigen and linked eukaryotic expression sequence; immunostimulation by expressing heterologous genes |
| 07/08/2008 | US7396821 Applying non-invasive external pressure against the skin of a limb of a mammal to impede blood flow; inserting a polynucleotide encoding a protein linked to a promoter into a blood vessel in vivo distal to the applied pressure; and administering immunosuppressive drugs |
| 07/08/2008 | US7396811 Subcellular targeting of therapeutic proteins |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396528 Exposing harvested tissue to concentration of an expression vector encoding cytokine; transplanting to eye; improving graft healing |
| 07/08/2008 | CA2357073C Nucleic acid molecules comprising the promoter for the prostate cancer marker pca3 and uses thereof |
| 07/08/2008 | CA2328296C Encapsulation devices with strand, yarn or mesh core |
| 07/08/2008 | CA2308124C Methods and compositions for inducing tumor-specific cytotoxicity |